electroCore Announces Top Line Results from SAVIOR-1 study of Non-Invasive Vagus Nerve Stimulation (nVNS) in Hospitalized COVID-19 Patients

NEXT STORY
Immutep Achieves Fast Track Designation From US FDA For Efti, A Soluble Lag-3 Protein, In First Line Recurrent/Metastatic Head & Neck Cancer
PREV STORY
Real World Evidence Solution Market Research Report by Component, by Therapeutic Area, by End-User – Global Forecast to 2025 – Cumulative Impact of COVID-19
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Forwardly’s Ligand Innovation Global Receives Significant Designations Under the Patent Cooperation Treaty

author_avatar
NASDAQ Market News

8.3% constant currency revenue growth in H1 as customers gradually return to labs

author_avatar
NASDAQ Market News

Claritas (formerly Kalytera Therapeutics, Inc.) Announces Addition of Professor Salvatore Cuzzocrea, Ph.D. to the Company’s Board of Directors

author_avatar
NASDAQ Market News